You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0465 An integrated safety data analysis across all phase ii and phase iii clinical programs for ustekinumab in psoriatic arthritis, crohn's disease, and psoriasis

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Psoriatic arthritis
SAT0465 An integrated safety data analysis across all phase ii and phase iii clinical programs for ustekinumab in psoriatic arthritis, crohn's disease, and psoriasis
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017802
Jul 20174001
Aug 20171800
Sep 20172800
Oct 20171202
Nov 20171400
Dec 20171601
Jan 20181805
Feb 20183803
Mar 20181801
Apr 20182601
May 20181600
Jun 20183000
Jul 20181600
Aug 20182000
Sep 2018802
Oct 2018400
Nov 2018602
Dec 2018602
Jan 2019804
Feb 2019802
Mar 2019804
Apr 2019803
May 2019002
Jun 2019604
Jul 2019202
Aug 20194306
Sep 2019001
Oct 2019208
Nov 2019102
Dec 2019200
Jan 2020200
Feb 2020001
Mar 2020804
Apr 2020201
May 2020001
Jun 2020403
Jul 2020600
Aug 2020403
Sep 20201802
Oct 20201004
Nov 2020202
Dec 2020601
Jan 2021201
Feb 2021603
Mar 2021604
Apr 2021301
May 2021805
Jun 2021101
Jul 2021005
Aug 2021001
Sep 2021001
Oct 20214019
Nov 20212016
Dec 20211001
Jan 2022801
Feb 2022400
Mar 2022802
Apr 20221202
May 2022805
Jun 20221503
Jul 20221000
Aug 20221402
Sep 2022606
Oct 2022403
Nov 20222101
Dec 20222002
Jan 20231602
Feb 20231001
Mar 20231500
Apr 2023100
May 2023002
Jun 2023400
Jul 2023203
Aug 2023201
Sep 2023200
Oct 2023200
Nov 2023001
Dec 2023600
Jan 2024400
Feb 2024401
Mar 20242032
Total7340210